Hansa Biopharma AB (publ) (STO:HNSA)
Sweden
· Delayed Price · Currency is SEK 29.34
-0.36 (-1.21%)
At close: Mar 9, 2026
Hansa Biopharma AB Market Cap
Hansa Biopharma AB has a market cap or net worth of 2.99 billion as of March 9, 2026. Its market cap has increased by 87.99% in one year.
Market Cap
2.99B
Enterprise Value
3.22B
Revenue
222.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
29.34
Market Cap Chart
Since April 24, 2008, Hansa Biopharma AB's market cap has increased from 30.71M to 2.99B, an increase of 9,621.62%. That is a compound annual growth rate of 29.18%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Flerie AB | 2.87B |
| Vicore Pharma Holding AB | 2.75B |
| Egetis Therapeutics AB | 2.04B |
| Diamyd Medical AB | 2.04B |
| Saniona AB | 2.01B |
| BioInvent International AB | 1.49B |
| Genovis AB (publ.) | 1.10B |
| Cantargia AB | 1.02B |